TCL Archive In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER March 20, 1992
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
